Abstract: The present application discloses a variety of airway sampling devices and associated methods. According to an embodiment, an airway sampling device for taking a sample from a subject's airway is provided with a handle to be gripped by a user when taking the sample and a sampling head carried by the handle, the sampling head comprising a cavity with an opening for entry by the sample and a sample collection membrane located within the cavity for receiving the sample.
Type:
Grant
Filed:
June 11, 2019
Date of Patent:
December 31, 2024
Assignees:
Hunt Developments (UK) Ltd., Imperial College Innovations Limited
Inventors:
Trevor T Hansel, Toby Hunt, Trevor Hunt, Duncan Hunt
Abstract: Embodiments of the disclosure include methods and compositions in which two inter-chromosomal or intra-chromosomal genomic DNA regions are rearranged upon exposure of the genomic DNA to a chimeric RNA that produces fusion of the two regions. The chimeric RNA hybridizes to the two different parts of the genomic DNA and forms a DNA/RNA hybrid in a sequence-specific manner, thereby facilitating genomic rearrangement. In particular embodiments this mechanism is utilized to produce directed gene fusion in targeted genomic DNA regions.
Abstract: A test device for indole concentrations in headspace gasses of bacterial cultures has a porous substrate imprinted with a wax barrier surrounding a test spot impregnated with p-dimethylaminocinnamaldehyde (DMACA). In embodiments, the test spot lies within a printed bar code and is configured to alter a reading of the bar code when the test spot darkens. The test device may optionally include a second test spot impregnated with Bromthymol Blue, Cobinamide, p-dimethylaminobenzaldehyde, or Chromotropic acid. The device is used by inoculating a sample into a culture; incubating the culture; inserting the test device into airspace of the culture, and observing the test spot for a color change indicative of indole presence.
Type:
Application
Filed:
September 6, 2024
Publication date:
December 26, 2024
Applicant:
Trustees of Dartmouth College
Inventors:
Alison Burklund, John X.J. Zhang, Harrison Saturley-Hall
Abstract: Methods and compositions are described for producing high-performance materials. These materials utilize layers of stacked tapes wherein the tapes in any given layer are offset by between 0.1 degrees and 45 degrees from tapes of adjacent layers. At least three roughly parallel tapes are included within each layer of tapes, and the tapes have an aspect ratio of at least 20. The maximum thickness of a tape within a given layer is 5 mm. The resulting materials have significantly improved strength and/or toughness. The compositions can be used as stand-alone materials or combined with other materials to form tape-reinforced composites.
Abstract: The present disclosure provides compositions and methods for treating neurodevelopmental disorders, such as Rett syndrome and cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder.
Type:
Application
Filed:
May 20, 2022
Publication date:
December 26, 2024
Applicants:
President and Fellows of Harvard College, Trustees of Tufts College
Inventors:
Richard Novak, Frederic Vigneault, Michael Levin, Donald E. Ingber
Abstract: A method and apparatus for evaluating soybean quality are disclosed. Automated or semi-automated image processing can be implemented with commercially available machine vision hardware. Post-harvest soybeans are separated, imaged, and analyzed to assess grain quality factors used in official grading. The system may be used prior to sale, purchase, further harvesting, or planting subsequent crops. The system reduces inspection errors, reduces variance in results, increases efficiency, enhances repeatability, and improves the standardization of soybean quality evaluation. Shape analysis, color analysis, and Haralick texture analysis are employed to determine when certain types of damage are present, to distinguish between types of damage, and to classify grains as smooth, cracked, or wrinkled. The system is sufficiently robust to allow successful deployment in rural, remote, and non-standard environments.
Type:
Application
Filed:
June 20, 2024
Publication date:
December 26, 2024
Applicant:
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
Abstract: A combination of markers (TMEM, MenaCalc, and MenalNV) for hematogenous metastatic cancer and their use for diagnosis, prognosis and predictive performance are disclosed.
Type:
Grant
Filed:
December 18, 2018
Date of Patent:
December 24, 2024
Assignee:
Albert Einstein College of Medicine
Inventors:
John S. Condeelis, Maja H. Oktay, Joan Jones, David Entenberg
Abstract: Systems and methods for estimating quantitative histological features of a subject's tissue based on medical images of the subject are provided. For instance, quantitative histological features of a tissue are estimated by comparing medical images of the subject to a trained model that relates histological features to multiple different medical image contrast types, whether from one medical imaging modality or multiple different medical imaging modalities. In general, the trained model is generated based on medical images of ex vivo samples, in vitro samples, in vivo samples or combinations thereof, and is based on histological features extracted from those samples. A machine learning algorithm, or other suitable learning algorithm, is used to generate the trained model. The trained model is not patient-specific and thus, once generated, can be applied to any number of different individual subjects.
Abstract: Methods and systems for monitoring the activity of electrogenic networks are described. One representative system includes an array of electrode coupled to an analyzer having a stimulator and a receiver. The electrode is placed in contact with an electrogenic cell. The electrodes can be shaped as nanowires, tubes, cavities and/or cones. The analyzer may be configured to operate in a voltage stimulation mode, in which the cells are stimulated via voltages and monitored via current, or in a current stimulation mode, in which the cells are stimulated via currents and monitored via voltages. The analyzers may be arranged as single-stage amplifiers, and may include a feedback loop shared between the stimulation signal path and the sensing signal path. The feedback loop may be arranged to provide overlapping stimulation and sensing of the electrogenic network's cells.
Type:
Grant
Filed:
October 30, 2018
Date of Patent:
December 24, 2024
Assignee:
President and Fellows of Harvard College
Inventors:
Donhee Ham, Hongkun Park, Keith Krenek, Tianyang Ye, Jeffrey T. Abbott, Wenxuan Wu
Abstract: A targeted DEFA5 antibody is disclosed herein. The targeted DEFA5 antibody has a high degree of specificity with DEFA5 protein, particularly with peptide sequences of the P, B, and/or M binding sites of the DEFA5 protein. The targeted DEFA5 antibody may be incorporated into an assay for diagnosing and treating ulcerative colitis and Crohns disease in a subject suffering from inflammatory bowel disease. The assay may be provided in a kit. The targeted DEFA5 antibody may be used in a method for measuring the level of DEFA5 or DEFA5 expression in a sample collected from a subject, and determining, based on the level of DEFA5 or DEFA5 expression, whether the subject is suffering from ulcerative colitis or Crohns disease. A treatment may be based on the determination of whether the subject has ulcerative colitis or Crohns disease.
Abstract: A circulator includes a central circuit having a first superconducting island, a second superconducting island, a third superconducting island, and a central island, each in electrical communication with each other via a plurality of Josephson junctions.
Type:
Grant
Filed:
September 17, 2021
Date of Patent:
December 24, 2024
Assignees:
University of Maryland, College Park, Government of the United states of America, as represented by the Secretary of Commerce
Abstract: The present disclosure provides a cellular foam composition, a method for producing and using the same. One particular aspect of the disclosure provides a cellular foam composition comprising a plurality of foam layers, where each foam layer is made from a hollow microstructure material. In particular, the density of the hollow microstructure material in each foam layer is different from the density of the hollow microstructure material that forms the adjacent foam layer. In some embodiments, cellular foam compositions of the disclosure further include an interfacial layer comprising interfacial voids in between adjacent layers.
Type:
Grant
Filed:
April 4, 2022
Date of Patent:
December 24, 2024
Assignees:
University of Maryland, College Park, Microsphere Material Solutions, LLC
Inventors:
Norman M. Wereley, Jungjin Park, John M. Howard, Matthew Demay, Avi Edery
Abstract: A rotary wing vehicle has a vehicle body. A gimbal assembly mounted to or within the body. A propeller assembly is mounted to the gimbal. The propeller assembly has first and second fixed pitch propellers. The gimbal assembly has a first gimbal rotatable about a first axis and a second gimbal rotatable about a second axis.
Type:
Application
Filed:
November 4, 2022
Publication date:
December 19, 2024
Applicant:
The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges
Abstract: The disclosure relates to compounds that demonstrate efficacy in blocking PACAP receptors (e.g. PAC1) and associated methods of treating neurological diseases or disorders using the disclosed compounds. The neurological diseases or disorders include, but are not limited to, stress-related diseases (e.g. chronic stress, post-traumatic stress disorder (PTSD), panic disorder, anxiety, or general anxiety disorder), pain-related diseases (e.g. chronic pain, primary headache disorders, or migraines), or addiction (e.g. addiction to a substance (e.g. addiction to cocaine, amphetamines, methamphetamine, methylphenidate, nicotine, alcohol, prescription medication, marijuana, tobacco, or an opioid selected from heroin, fentanyl, codeine, hydrocodone, morphine, oxycodone, hydromorphone, and methadone)).
Type:
Application
Filed:
October 7, 2022
Publication date:
December 19, 2024
Applicant:
The University of Vermont and State Agricultural College
Inventors:
Victor May, Matthias Brewer, Jianing Li
Abstract: Disclosed herein is a class of molecules termed remodilins that inhibit serum response factor (SRF). By inhibiting SRF, a number of downstream pathways can be targeted. The remodilins can be used to treat glaucoma, inhibit tumor cell growth, inhibit tumor metastasis, inhibit hypoxia-induced response, and/or reduce cellular metabolism.
Type:
Application
Filed:
March 14, 2024
Publication date:
December 19, 2024
Applicants:
The University of Chicago, The United States of America, as Represented by the Secretary, Department of Health and Human, President and Fellows of Harvard College, IIT Research Institute, Beth Israel Deaconess Medical Center, Inc.
Inventors:
Julian SOLWAY, Nickolai DULIN, Marsha ROSNER, Gokhan MUTLU, Diane LUCI, David MALONEY, Chan Young PARK, Jeffrey FREDBERG, David MCCORMICK, Ramaswamy KRISHNAN
Abstract: G protein-coupled receptor (GPCR) regulators and methods for their use are provided herein. The GPCR regulators described herein are useful in treating and/or preventing conditions or diseases associated with a GPCR, including ageing, cancer, cardiovascular disorders, hematologic disorders, infectious diseases, inflammatory diseases, metabolic diseases, neurodegenerative disorders, respiratory diseases, or urological disorders. Also provided are methods of regulating a G protein-coupled receptor in a cell using the compounds and compositions described herein.
Type:
Application
Filed:
October 11, 2022
Publication date:
December 19, 2024
Applicant:
Baylor College of Medicine
Inventors:
Damian Winston Young, Srinivas Chamakuri, Conrad Santini, Martin M. Matzuk, Kevin A. Tran, Prashi Jain, Shiva Krishna Reddy Guduru, Idris O. Raji, Errol L.G. Samuel, Kevin R. MacKenzie
Abstract: The present invention generally relates to emulsions, and more particularly, to multiple emulsions. In one aspect, multiple emulsions are formed by urging a fluid into a channel, e.g., by causing the fluid to enter the channel as a “jet.” Side channels can be used to encapsulate the fluid with a surrounding fluid. In some cases, multiple fluids may flow through a channel collinearly before multiple emulsion droplets are formed. The fluidic channels may also, in certain embodiments, include varying degrees of hydrophilicity or hydrophobicity. As examples, the fluidic channel may be relatively hydrophilic upstream of an intersection (or other region within the channel) and relatively hydrophobic downstream of the intersection, or vice versa. In some cases, the average cross-sectional dimension may change, e.g., at an intersection. For instance, the average cross-sectional dimension may increase at the intersection.
Type:
Application
Filed:
April 4, 2024
Publication date:
December 19, 2024
Applicant:
President and Fellows of Harvard College
Inventors:
David A. Weitz, Julian W.P. Thiele, Adam R. Abate